Skip to main content

Table 1 Distribution of stroke cases and controls by type and CT/OS component

From: Exploring the interaction between SNP genotype and postmenopausal hormone therapy effects on stroke risk

 

E-alone

E+P

CaD

DM

CT

OS

Overall cases

351

438

838

1,110

1,672

373

Ischemic

263

319

575

695

1,110

226

Hemorrhagic

48

76

132

190

280

61

Other cases

40

43

131

225

282

86

Controls

351

438

838

1,110

1,672

373

  1. CaD, calcium and vitamin D versus placebo supplementation; CT, randomized controlled trial; DM, low-fat dietary modification versus usual diet; E-alone, estrogen versus placebo; E+P, estrogen plus progestin versus placebo; OS, observational study.